Correlation Between Lipocine and Agilent Technologies
Can any of the company-specific risk be diversified away by investing in both Lipocine and Agilent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Agilent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Agilent Technologies, you can compare the effects of market volatilities on Lipocine and Agilent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Agilent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Agilent Technologies.
Diversification Opportunities for Lipocine and Agilent Technologies
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lipocine and Agilent is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Agilent Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agilent Technologies and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Agilent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agilent Technologies has no effect on the direction of Lipocine i.e., Lipocine and Agilent Technologies go up and down completely randomly.
Pair Corralation between Lipocine and Agilent Technologies
Given the investment horizon of 90 days Lipocine is expected to generate 3.26 times more return on investment than Agilent Technologies. However, Lipocine is 3.26 times more volatile than Agilent Technologies. It trades about 0.01 of its potential returns per unit of risk. Agilent Technologies is currently generating about -0.01 per unit of risk. If you would invest 765.00 in Lipocine on August 23, 2024 and sell it today you would lose (294.00) from holding Lipocine or give up 38.43% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Lipocine vs. Agilent Technologies
Performance |
Timeline |
Lipocine |
Agilent Technologies |
Lipocine and Agilent Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and Agilent Technologies
The main advantage of trading using opposite Lipocine and Agilent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Agilent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will offset losses from the drop in Agilent Technologies' long position.Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Agilent Technologies vs. Danaher | Agilent Technologies vs. Illumina | Agilent Technologies vs. IDEXX Laboratories | Agilent Technologies vs. Waters |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |